PERICOLINI, Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.143
AS - Asia 7.361
EU - Europa 6.959
SA - Sud America 1.052
Continente sconosciuto - Info sul continente non disponibili 293
AF - Africa 209
OC - Oceania 57
Totale 33.074
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.592
SG - Singapore 2.234
IT - Italia 2.033
GB - Regno Unito 1.851
CN - Cina 1.689
HK - Hong Kong 825
BR - Brasile 752
VN - Vietnam 712
DE - Germania 560
SE - Svezia 502
BD - Bangladesh 419
RU - Federazione Russa 302
FR - Francia 284
UA - Ucraina 260
FI - Finlandia 256
IN - India 239
KR - Corea 238
TR - Turchia 232
CA - Canada 228
ID - Indonesia 204
PL - Polonia 163
BG - Bulgaria 121
MX - Messico 114
AR - Argentina 94
IQ - Iraq 81
RO - Romania 81
NL - Olanda 77
JP - Giappone 73
BE - Belgio 65
ZA - Sudafrica 65
ES - Italia 52
IE - Irlanda 50
MY - Malesia 49
EC - Ecuador 48
LT - Lituania 46
PK - Pakistan 46
HU - Ungheria 45
AE - Emirati Arabi Uniti 44
AU - Australia 44
CL - Cile 44
CO - Colombia 43
AT - Austria 41
IR - Iran 39
IL - Israele 32
PT - Portogallo 31
CR - Costa Rica 29
EG - Egitto 29
MA - Marocco 27
TT - Trinidad e Tobago 27
CH - Svizzera 26
TH - Thailandia 26
HN - Honduras 25
PE - Perù 25
PH - Filippine 25
UZ - Uzbekistan 25
NO - Norvegia 22
GT - Guatemala 21
JM - Giamaica 21
VE - Venezuela 20
CZ - Repubblica Ceca 18
DZ - Algeria 18
PY - Paraguay 16
SA - Arabia Saudita 16
SV - El Salvador 16
TW - Taiwan 16
GP - Guadalupe 15
PR - Porto Rico 15
CW - ???statistics.table.value.countryCode.CW??? 13
AZ - Azerbaigian 12
GR - Grecia 12
KE - Kenya 12
NP - Nepal 12
DO - Repubblica Dominicana 11
JO - Giordania 11
NZ - Nuova Zelanda 11
TN - Tunisia 11
DK - Danimarca 10
BB - Barbados 9
EE - Estonia 8
KW - Kuwait 8
OM - Oman 8
SC - Seychelles 8
SK - Slovacchia (Repubblica Slovacca) 8
NI - Nicaragua 7
BO - Bolivia 6
ET - Etiopia 6
LB - Libano 6
LV - Lettonia 6
PA - Panama 6
UG - Uganda 6
KG - Kirghizistan 5
QA - Qatar 5
RS - Serbia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
CG - Congo 4
CI - Costa d'Avorio 4
KZ - Kazakistan 4
LK - Sri Lanka 4
MT - Malta 4
Totale 32.729
Salva come PNG Salva come JPEG
Città #
Ashburn 1.864
Santa Clara 1.601
Singapore 1.587
Fairfield 1.343
Southend 1.065
San Jose 959
Council Bluffs 855
Woodbridge 789
Hong Kong 783
Chandler 631
Houston 578
Seattle 499
Wilmington 426
Jacksonville 392
Hefei 383
Cambridge 382
Dearborn 380
Beijing 378
London 321
Ann Arbor 311
Modena 264
Nyköping 262
Los Angeles 259
New York 248
Ho Chi Minh City 217
Seoul 202
Milan 167
The Dalles 164
Hanoi 159
Helsinki 151
Dallas 140
Jakarta 138
San Diego 124
Buffalo 122
Sofia 113
Chicago 111
Princeton 109
Kraków 101
Bologna 100
Bremen 99
Lauterbourg 99
Rome 97
Columbus 94
Eugene 91
Moscow 83
São Paulo 77
Redwood City 76
Orem 75
Boardman 72
Izmir 64
Tokyo 62
Chennai 57
Phoenix 57
Timisoara 57
Carpi 56
Reggio Emilia 56
Shanghai 55
Atlanta 54
Exeter 54
Nuremberg 50
North Bergen 47
Toronto 47
Montreal 45
Warsaw 43
Denver 42
Haiphong 42
Munich 42
Frankfurt am Main 41
Guangzhou 41
Johannesburg 40
Mexico City 39
Da Nang 38
Nanjing 38
Parma 38
Brooklyn 37
Dublin 37
San Francisco 34
Verona 33
Dong Ket 32
Brussels 31
Naples 30
Porto Alegre 30
Salt Lake City 30
Baghdad 28
Mumbai 28
Perugia 28
Amsterdam 26
Boston 26
Stockholm 26
Florence 25
Norwalk 25
Trieste 25
Poplar 24
San José 24
Springfield 24
Dongguan 23
Falls Church 23
Rio de Janeiro 23
Turin 23
Kent 22
Totale 21.463
Salva come PNG Salva come JPEG
Nome #
Zinc treatment prevents neutrophil recruitment and inflammation by blocking Candida albicans Pra1 during vulvovaginal candidiasis. 957
Evaluation of benzydamine effects on Candida albicans adhesion, biofilm formation and persistence onto abiotic surfaces 503
Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response 496
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 458
Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro 421
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 413
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 405
In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. 400
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 398
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 379
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 377
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 369
Antibody Constant Region Peptides Can Display Immunomodulatory Activity through Activation of the Dectin-1 Signalling Pathway 367
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 363
Effects of different mouthwashes on biofilm formation by oral streptococci 358
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 351
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 341
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 337
Antibacterial Effects of MicroRepair®BIOMA-Based Toothpaste and Chewing Gum on Orthodontic Elastics Contaminated In Vitro with Saliva from Healthy Donors: A Pilot Study 336
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 335
A Purified Capsular Polysaccharide Markedly Inhibits Inflammatory Response during Endotoxic Shock 334
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 333
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration 329
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 328
Effects of different mouthwashes on Candida albicans adhesion, susceptibility to phagocytic cells and capacity to elicit pro-inflammatory cytokine response 327
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 326
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 324
Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity 319
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 316
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice 306
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 303
Mouse Strain-Dependent Differences in Estrogen Sensitivity During Vaginal Candidiasis 303
A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production 300
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis 297
Hyphal morphology, molecular genetics and phylogenetic relationships among commensal and pathogenic vulvovaginal isolates of Candida albicans 297
The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection 286
Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence 286
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 284
Functional Improvement of Regulatory T Cells From Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan 283
A novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice 276
The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients 275
Peptides of the constant region of antibodies display fungicidal activity 269
Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide. 267
Role of CD45 signaling pathway in Galactoxylomannan-induced T cell damage 267
Inflammatory response during human vaginal infection with Candida albicans 267
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 267
Saccharomyces cerevisiae as a new therapeutic agent against oropharyngeal candidiasis 264
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 264
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus, Lactobacillus (L.) acidophilus, Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus 261
NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans 261
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration. 261
Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy 261
Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression 259
Experimental models of vaginal candidiasis and inflammation 256
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 255
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis 250
The Candida albicans Pra1 zincophore promotes neutrophils recruitment and inflammation during vulvovaginal candidiasis 249
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 246
GILZ restrains neutrophil activation by inhibiting the MAPK pathway 246
A role for secretory aspartyl proteinase of Candida albicans in mouse vaginal inflammation and vaginal candidiasis 244
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 244
Comparative analysis of commensal and pathogenic vulvovaginal clinical isolates of Candida albicans: hyphal morphology, molecular genetics and phylogenetic relationships 242
THE PROTECTIVE ROLE OF TYPE-I INTERFERONS AXIS ACTIVATION IN THE VULVOVAGINAL CANDIDIASIS MODEL 239
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro 237
It takes two to tango: how a dysregulation of the innate immunity, coupled with Candida virulence, triggers VVC onset 237
Cryptococcus neoformans capsular polysaccharide component Galactoxylomannan induces apoptosis of human T cells through activation of Caspase-8 234
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 231
Involvement of glycoreceptors in galactoxylomannan-induced T cell death 228
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response 227
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 227
Elucidating the immunological function of the Cryptococcus neoformans capsule 224
Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis 224
A role for Cryptococcus neoformans galactoxylomannan in T cell apoptosis and function. 222
Chronic vaginal candidiasis is achievable in outbred CD-1 mice 222
Indinavir influences biological function of dendritic cells and stimulates antifungal immunity 222
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response. 221
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges 219
Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome 218
A new strategy to prevent biofilm and clot formation in medical devices: the use of atmospheric non-thermal plasma assisted deposition of silver-based nanostructured coatings 215
Gray phenotype: enhanced fitness strategy for Candida dubliniensis 214
A microbial polysaccharide reduces the severity of rheumatoid arthtritis via inhibition of Th17 differentiation 213
The GITRL-GITR system alters TLR-4 expression on DC during fungal infection 213
Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor 212
Immunomodulatory properties of heat-inactivated biomasses by selected bacterial and fungal species included in the Qualified Presumption of Safety list of the European Food Safety Authority 211
Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts 211
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 209
The Propionibacterium spp. extract reduces Candida albicans-induced damage to vaginal epithelial cells and increases mitochondrial response to Candida albicans infection in vitro 209
Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages 208
In vivo induction of neutrophils chemotaxis by secretory aspartyl proteinases of Candida albicans 208
Candidalysin is a key player in activating vaginal cell ROS in an in vitro infection model 207
Evaluation of Anti-Candida Activity of Vitis vinifera L. Seed Extracts Obtained from Wine and Table Cultivars 207
Any antibody fragment might exert antifungal activity 206
Therapeutic activity of Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 205
Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages 205
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity 198
The pathogenic and colonization potential of Candida africana 195
Comparison between bioluminescence imaging technique and CFU count for the study of oropharyngeal candidiasis in mice 194
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 192
Cutibacterium acnes lysate improves cellular response against Candida albicans, Escherichia coli and Gardnerella vaginalis in an in vitro model of vaginal infection 192
Biological Features, Antimicrobial Susceptibility and Phenotypic Characterization of Candidozyma auris CDC B11903 Grown at Different Temperatures 192
Totale 28.344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.232 0 0 0 0 46 98 103 92 197 166 330 200
2022/20232.193 181 161 202 203 293 272 67 212 298 62 122 120
2023/20241.961 80 124 147 123 244 251 142 252 73 163 149 213
2024/20255.335 200 120 127 394 1.165 850 266 365 519 383 430 516
2025/20269.851 542 380 572 1.171 1.275 706 1.168 559 935 1.071 879 593
2026/20273.851 674 809 904 1.189 275 0 0 0 0 0 0 0
Totale 33.074